Codexis, Inc.
Symbol: CDXS (NASDAQ)
Company Description:
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
- Today's Open: $2.43
- Today's High: $2.485
- Today's Low: $2.4
- Today's Volume: 624.85K
- Yesterday Close: $2.45
- Yesterday High: $2.46
- Yesterday Low: $2.4
- Yesterday Volume: 431.74K
- Last Min Volume: 83
- Last Min High: $2.425
- Last Min Low: $2.425
- Last Min VWAP: $2.425
- Name: Codexis, Inc.
- Website: https://www.codexis.com
- Listed Date: 2010-04-22
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001200375
- SIC Code: 2860
- SIC description: INDUSTRIAL ORGANIC CHEMICALS
- Market Cap: $221.16M
- Round Lot: 100
- Outstanding Shares: 90.27M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | S-8 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-08-04 | 4 | View |
| 2025-07-31 | 4 | View |
| 2025-07-30 | SCHEDULE 13G | View |
| 2025-07-22 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 8-K | View |
| 2025-05-28 | 4 | View |